Recurrent Glioblastoma

Novel cancer vaccine approach for brain tumors

Glioblastoma is the most common aggressive primary brain tumor, and despite advances in standard treatment, the median survival is about 15 months (compared to 4 months without treatment). Researchers at Thomas Jefferson ...

Nov 13, 2014
popularity 5 / 5 (1) | comments 0

Brain cancer vaccine proves effective

A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients ...

Apr 17, 2012
popularity 5 / 5 (1) | comments 0 | with audio podcast
  • Pages: 1

Latest Spotlight News

More genetic clues found in a severe food allergy

Scientists have identified four new genes associated with the severe food allergy eosinophilic esophagitis (EoE). Because the genes appear to have roles in other allergic diseases and in inflammation, the ...

Dominant people can be surprisingly social

In contrast to the lay stereotype, dominant people prove to be avid social learners, just like dominant individuals in the animal kingdom. Neuroscientists from Radboud University show this with a complex ...